MedPath

Dietary intervention trial: single blinded placebo-controlled, randomized study to assess anti-diabetic effects of daily bitter gourd consumption among pre-diabetics in Moshi, Tanzania

Not Applicable
Conditions
Pre-diabetes
Registration Number
DRKS00005131
Lead Sponsor
Bundesministerium für wirtschaftliche Zusammenarbeit und Entwicklung (BMZ)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
90
Inclusion Criteria

BMI > 27 - < 35 kg/m²
-WC > 80 cm (women) > 94 cm (men)
-Being pre-diabetic according to:
-Fasting plasmae glucose (FPG) = 100 – 125 mg/dl (= 5.6 – 6.9 mmol/l) on two screening days or FPG = 100 – 125 mg/dl and HbA1c = 5.7% < 6.5% on one screening day

Exclusion Criteria

-Having diagnosed disease
-Having G6PD deficiency
-Taking any kind of medication regularly
-High blood pressure (>140/>90)
-Low blood pressure (<90/<60)
-Being mentally ill
-Pregnancy or planned pregnancy
-Breast-feeding
-Heavy alcohol consumption

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fasting plasma glucose: measured each at baseline and after each intervention of eight weeks (end assessment) as well as during the weekly check-ups.
Secondary Outcome Measures
NameTimeMethod
HbA1c, insulin, triglycerides, high-density lipoprotein, cholesterol:measured each at baseline and after each intervention of eight weeks (end assessment)<br>Body weight, waist circumference, blood pressure: measured each at baseline and after each intervention of eight weeks (end assessment) as well as during the weekly check-ups.
© Copyright 2025. All Rights Reserved by MedPath